2 completed, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Sichuan Purity Pharmaceutical Technology Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults PRT-064040 nasal spray, Placebo - Migraine | Phase 2 | Recruiting | Sichuan Purity Pharmaceutical Technology Co., Ltd. | 456 | 2026-01-26 | 2026-01-29 |
| A Study to Learn About PRT-064040 Nasal Spray in Healthy Adult Subjects PRT-064040 nasal spray, Placebo - Migraine | Phase 1 | Completed | Sichuan Purity Pharmaceutical Technology Co., Ltd. | 80 | 2025-06-07 | 2025-12-04 |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior Low Dose PRT042 nasal spray, median Dose PRT042 nasal spray, high dose PRT042 nasal spray - Major Depressive Disorder (MDD | Phase 2 | Completed | Sichuan Purity Pharmaceutical Technology Co., Ltd. | 98 | 2025-05-27 | 2026-09-09 |
Migraine Disorders (2) · Depressive Disorder, Major (1)
China (3)